R5 Pharmaceuticals develops and manufactures prototype dosage forms for clinical trials. We make the products that the volunteers and patients will take during a clinical study.
Behind these simple statements is a huge amount of know how, skill and experience in providing the right product on time and on budget. Our team of experienced formulators, analytical chemists, QC staff and QPs are a powerful resource at your disposal. R5 is licensed by MHRA for the manufacture and testing of investigational materials by MHRA. Our licence and GMP Certificate is available on request.
We are based at laboratories at BioCity Nottingham, one of Europe’s largest bioscience incubators. R5 has 40 staff. Our GMP facilities produce a wide range of dosage forms including, tablets, capsules, creams, ointments, terminally sterilised and aseptically prepared injectables. This is backed up by a fully equipped analytical chemistry laboratory for method development, QC and stability testing. Clinical products are released by our QPs. R5 is the ideal provider of the complete CMC service to pharmaceutical and biotech companies moving into clinical trials.
R5 can formulate and analyse both synthetic and biotech materials, including cytotoxic APIs, proteins and peptides.
Customers have come to R5 from most parts of the pharma and biotech map including USA, Japan, Korea, Australia, New Zealand and the EU.
R5 is unique in providing a showcase for new GMP technologies. R5 provides all the GMP services to accommodate technologies that do not have their own GMP facilities. Customers are encouraged to evaluate these new technologies with the knowledge that the expertise is provided by the inventor together with R5 and be confident that clinical materials will be made with the assurance of R5 GMP.
The R5 Technology ShowCase currently comprises:
R5 Pharmaceuticals Ltd
Nottingham NG1 1GF